Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales | Fierce Pharma
Vas Narasimhan | MCAAD
Novartis on LinkedIn: Today we announced appointment of Vasant (Vas) Narasimhan, M.D., Global… | 281 comments
Performance slump takes toll on Novartis' CEO's 2022 payout
Novartis CEO Vas Narasimhan on Culture, Strategy and Change
Vas Narasimhan, chief executive officer of Novartis AG, during an... Fotografía de noticias - Getty Images
La FDA da luz verde al fármaco de Novartis
It'll take more than vaccines to fight covid-19, says Novartis CEO Vas Narasimhan | Mint
The CEO of Novartis on Developing Drugs During a Pandemic | WIRED
Vas Narasimhan: El médico de 42 años que pasó de tratar la malaria en Gambia a dirigir un gigante farmacéutico | Líderes
Novartis' CEO on gene therapy, innovation, and the company pivot - STAT
Novartis inicia una revisión exhaustiva de Beovu por sus efectos adversos
Una vacuna no bastará para combatir el covid, dice jefe de Novartis
novartis: Who is Vas Narasimhan? All about the new global chief executive of Swiss pharma giant Novartis - The Economic Times
Vas Narasimhan Ceo Novartis Attends Panel Foto de stock de contenido editorial - Imagen de stock | Shutterstock
Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company | Ceo, Development, Company
Novartis CEO's pay rises 21% as Roche's new chief nets $11M
Novartis - Today we announced appointment of Vasant (Vas) Narasimhan, M.D., Global Head of Drug Development and Chief Medical Officer, as the new CEO of Novartis, effective February 1, 2018. We thank
Vas Narasimhan, CEO de la farmaceútica Novartis | XLSemanal
30 fotos e imágenes de Novartis Ceo Vas Narasimhan Interview - Getty Images
Novartis CEO Vas Narasimhan on M&A and Taking Earlier Risks on New Technology
